SQURPHARMA

Square Pharmaceuticals PLC. · Pharmaceuticals and Chemicals · Cat A

85/100

Strong

৳221.4

Score breakdown

Technical read

RSI (14)56.9

MACDbearish

Bollingerinside bands (+0.2σ)

Price cycle (Wyckoff)MARKUP

Health trendimproving

Flow pressureneutral

Valuation

Fair value486.7 (340.7-632.7)

Upside+120.00%

Dividend yield+5.40%

Fundamental verdictSUSTAINABLE

ConfidenceLOW (re-rate ceiling, not target)

Levels

Resistance

৳225

৳234.1

৳242

৳249.8

Support

৳220.5

৳210.6

৳201.1

৳190

Historical bounce zones

Jan 14, 2020: ৳153.3→৳201.5 +31%

Mar 18, 2020: ৳149.1→৳186.8 +25%

Jun 2, 2020: ৳164.3→৳210 +28%

Nov 30, 2020: ৳183→৳247 +35%

Apr 4, 2021: ৳190→৳251.9 +33%

Jun 11, 2024: ৳197.2→৳244.8 +24%

May 28, 2025: ৳198.9→৳234.1 +18%

Jan 1, 2026: ৳198→৳236 +19%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -4.7% / -1% / 3.9%

30-day 41% vs 42% market avg Typical move: -8.3% / -1.5% / 7%

Signals: Bullish Harami

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readdip to 215.0–220.9

Reference stopclose<214.3 (buffer)

Reference targetride/trail; ref 255.8

Timing notebuy dips Jun-Aug; trim Sep-Oct; hold+trail

Organic (score 21) — clean price history; historically holds its uptrend above the 50-day average. Real earnings. Balance sheet RECOVERING (Z rising). [fundamentals SUSTAINABLE, payout 44.0%, yield 5.4%]

Market activity

Insider activity (disclosed)

Buy 0 / Sell 0 in the last 90 days.